Almac Pharma Services, a product development and commercial manufacture partner to the international pharmaceutical industry, today announced that MiddleBrook Pharmaceuticals, a pharmaceutical company committed to developing anti-infective products that fulfill unmet medical needs, has retained Almac to provide packaging services for physician samples of MOXATAG (amoxicillin extended-release) tablets, 775mg. Almac Pharma Services will work closely with MiddleBrook’s chosen commercial manufacturer, STADA Production Ireland®.
“MOXATAG samples will be a key element of our nationwide launch to health care professionals in March 2009,” MiddleBrook president and CEO John Thievon said. “Physician samples allow doctors to quickly initiate treatment in conjunction with a patient’s office visit. Almac will provide services integral to the MOXATAG launch and we’re pleased to have Almac as a partner.”
Almac Pharma Services vice president of commercial operations David Downey said, “Almac is delighted to be working with MiddleBrook to produce sample packs in support of the MOXATAG product launch.”
